Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency (Q45877567)

17 December 2017

title

Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency (English)

1 reference

17 December 2017

author name string

T Yoshikawa

1

1 reference

17 December 2017

T Niwa

2

1 reference

17 December 2017

H Mizuguchi

3

1 reference

17 December 2017

N Okada

4

1 reference

17 December 2017

S Nakagawa

5

1 reference

17 December 2017

publication date

15 May 2008

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

19

1 reference

17 December 2017

page(s)

1321-1329

1 reference

17 December 2017

Cutting Edge: CpG DNA inhibits dendritic cell apoptosis by up-regulating cellular inhibitor of apoptosis proteins through the phosphatidylinositide-3'-OH kinase pathway.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

bcl-xL is critical for dendritic cell survival in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Dendritic-cell trafficking to lymph nodes through lymphatic vessels

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

The use of dendritic cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

The first 1000 dendritic cell vaccinees.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Immune tolerance after delivery of dying cells to dendritic cells in situ

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

A new lease on life for dendritic cell vaccines?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Regulation of the lifespan in dendritic cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Bcl-2 controls dendritic cell longevity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

A Bcl-2-dependent molecular timer regulates the lifespan and immunogenicity of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Protection against ischemic brain injury by protein therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Death receptors: signaling and modulation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

An essential role for Akt1 in dendritic cell function and tumor immunotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Rapid construction of small interfering RNA-expressing adenoviral vectors on the basis of direct cloning of short hairpin RNA-coding DNAs

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Generation of dendritic cell-based vaccines for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.85

7 January 2021

Identifiers

DOI

10.1038/GT.2008.85

1 reference

17 December 2017

Dimensions Publication ID

1020340535

0 references

1 reference

17 December 2017